We are a pharmaceutical company focused on developing, manufacturing and distributing innovative drugs in the People's Republic of China ("China" or PRC"). Additionally, through our 10 retail pharmacy locations in Beijing, China, we sell Western and traditional Chinese medications, and medical treatment equipment.

We were incorporated on January 28, 2004 in the State of Nevada as S.E. Asia Trading Company, Inc. ("SEAA") to sell jewelry and home accessories. The Company's name was changed to Lotus Pharmaceuticals, Inc. on December 6, 2006.

On September 6, 2006, we entered into a definitive Share Exchange Agreement with Lotus Pharmaceutical International, Inc. ("Lotus International"), whereby we would acquire all of the outstanding common stock of Lotus International in exchange for newly-issued stock of Lotus to Lotus International's shareholders. Lotus International was incorporated under the laws the State of Nevada on August 28, 2006 to develop and market pharmaceutical products in China. On September 28, 2006, Lotus International became our wholly-owned subsidiary and Lotus International's shareholders own the majority of our voting stock. The acquisition of Lotus International by us was accounted for as a reverse merger because on a post-merger basis, the former shareholders of Lotus International held a majority of our outstanding common stock on a voting and fully-diluted basis. As a result, Lotus International is deemed to be the acquirer for accounting purposes.